Healthcare Middle East Update 1st August 2005

This month we take a look at just some of the people who help make Healthcare Middle East the leading publication for healthcare professionals in the Gulf.

  • E-Mail
By  Stuart Qualtrough Published  August 3, 2005

Meet the Board|~||~||~|This month we take a look at the Editorial Advisory Board of Healthcare Middle East. Collectively, they are responsible for ensuring the relevance, accuracy and balance of articles and features to maintain the magazine’s position as the leading publication for healthcare professionals in the Gulf. Our emphasis is to deliver a consistently high quality product and our board is made up of some of the most distinguished healthcare leaders in the region:

Michael Stroud, CEO Welcare Hospital.

Michael Stroud is the chief executive officer of the Welcare Hospital in Dubai. A seasoned healthcare executive with over 15 years experience at CEO level of managing hospitals in the UAE and UK, he is a popular and well-respected healthcare leader within the region. His strong clinical background enables him to have an extensive understanding of what drives hospitals and therefore analytical and pragmatic approach to strategic and operational issues. He has in total managed 4 private hospitals, which includes the Wellington Hospital in London, which is the largest private hospital in the UK.


Dr Ahmed M. El Hakim, Health Policy & External Affairs Director, Pfizer Middle East.

Ahmed M. El Hakim joined Pfizer Egypt in 1977, in the sales department. Over the years, he held different positions of increasing responsibility for Pfizer, in Egypt and the Middle East, in sales and marketing. In 1992, he was appointed general manager for Pfizer in Saudi Arabia, where he stayed until 1996, when he was located in Dubai as regional manager for the Middle East Arab Group (MEAG). Dr El Hakim has been in his current position since 1998, contributing to the growth of the external affairs’ function as one of the core competencies for Pfizer and the research-based pharmaceutical industry. In this current role, he also sits on the Management Leadership Team for Middle East Business. He is a member of the executive committee of the Pharmaceutical Research & Manufacturers Association of the Gulf (PhRMAG) and the secretary-general of the Egyptian Association for Research & Manufacturers of Pharmaceuticals (PhRMA-Egypt). He is a Licensing Executives Society (LES) member (USA & Canada). Dr. El Hakim holds a Bachelor’s of Science in veterinary medicine from Cairo University.


Dr Robert Thurer, chief academic officer of Harvard Medical School Dubai Centre.

Dr Thurer has been an active member of the Faculty of Medicine at Harvard Medical School and a successful cardiothoracic surgeon and clinical educator at Beth Israel Deaconess Medical Center for the past 25 years. A graduate of Dartmouth College and a member of its governing board, as well as a graduate of Harvard Medical School, he completed his general and thoracic surgical training at Massachusetts General Hospital.
Dr Thurer is a recognised expert in the fields of surgery of the lung and thorax as well as blood use in surgery, and he has published extensively on many topics including blood conservation and lung cancer. He is a contributing editor for Cardiothoracic Digest and a reviewer for the New England Journal of Medicine, Journal of the American Medical Association, Journal of Thoracic and Cardiovascular Surgery, and many other leading publications.


Dr Andrew Barrer, acting CEO of the Centre for Healthcare Planning and Quality (CPQ) of the Dubai Health Care City.

Dr. Barrer has over twenty years experience in health care delivery and management.
Beginning in 1979 he began one of the first freestanding medical rehabilitation hospitals in the USA dedicated to head and spinal cord injury rehabilitation. In 1986 Dr. Barrer became a Clinical Professor and Chairman of the University of Wisconsin Health Care Corporation, one of the country’s largest university healthcare systems. In 1992 following the election of President Clinton, Dr. Barrer was appointed to manage the transition of the Health Care Financing Administration (HCFA), the US agency that operates the Medicare and Medicaid programs. In the following year Dr. Barrer became the President’s Senior Advisor for Health Care at The White House where he focused on the health care budget, international health issues and relationships with the private sector.
In 1997 Dr. Barrer continued his focus on international health by managing a large multicountry project for The World Bank, which related to health care reform in middle income countries. In recent years, Dr. Barrer has managed projects in more than 25 countries including a large EU project regarding Russian health management reform.
||**||

Add a Comment

Your display name This field is mandatory

Your e-mail address This field is mandatory (Your e-mail address won't be published)

Security code